Reduced thymic IL-4 impairs negative T cell selection in nonobese diabetic mice

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Type 1 diabetes (T1D) arises despite existing central tolerance mechanisms.
• The role of thymic cytokine microenvironment in T1D pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the impact of Interleukin-4 (IL-4) on thymic T cell selection and its role in preventing Type 1 diabetes (T1D).
• To understand the mechanism by which IL-4 influences early thymic progenitor (ETP) fate and T cell receptor (TCR) repertoire.

Main Methods:

• Analysis of IL-4/IL-13 heteroreceptor (HR) signaling in ETPs.
• Assessment of STAT transcription factor activation.
• Evaluation of dendritic cell (DC) populations and T cell selection processes in nonobese diabetic (NOD) mice.
• Quantification of invariant natural killer T (iNKT) 2 cell frequency.

Main Results:

• Intrathymic IL-4 enrichment enhances negative selection of self-reactive T cells and promotes a diverse T cell repertoire.
• Optimal IL-4 signaling programs ETPs toward CD11c+CD8α+ dendritic cells, crucial for clonal deletion of diabetogenic T cells.
• Diminished iNKT 2 cell frequency in NOD mice leads to suboptimal IL-4 levels, impairing ETP differentiation towards DCs and resulting in reduced negative selection and T1D.

Conclusions:

• IL-4 plays a critical role in thymic central tolerance and T1D prevention.
• Dysfunctional IL-4 signaling, linked to iNKT cell deficiency, contributes to the breakdown of self-tolerance and the development of T1D in NOD mice.
• Targeting IL-4 pathways presents a potential therapeutic strategy for T1D.